PeptiMimesis is a strategic partner in the design, the discovery and the early development of transmembrane therapeutic peptides
Location: France, Great East, Illkirch-Graffenstaden
Total raised: $1.36M
Investors 1
| Date | Name | Website |
| - | Capital Gr... | capitalgra... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 20.04.2016 | - | $1.36M | - |
Mentions in press and media 3
| Date | Title | Description |
| 08.06.2020 | Find Therapeutics, a new drug development company dedicated to breakthrough therapies against rare diseases launches in Montreal | The new company raises initial capital to develop transmembrane peptides against GPCRs to address high unmet needs. Montreal, Canada – June 8, 2020: CTI Life Sciences, along with partners adMare BioInnovations, Domain Therapeutics and Pepti... |
| 15.03.2017 | PeptiMimesis Raises Second Seed Funding Tranche | PeptiMimesis, a Strasbourg, France-based biopharma company dedicated to the discovery and development of therapeutic transmembrane peptides, raised €700k ($740k) in the second seed funding tranche. Regional seed fund Cap Innov’Est made the ... |
| 20.04.2016 | PeptiMimesis Secures €1.2M in Funding | PeptiMimesis, a Strasbourg, France-based biopharma company, closed a €0.5m ($0.6m) first tranche of a €1.2m ($1.4m) funding round. The investment was made by Cap Innov’Est, a regionally-based seed fund. The company will use the funds to ini... |